Skip to content

CLOSSON

Active
Private limited company·Groothandel in farmaceutische en medische artikelen· 14 yrs active
Rue Houchettes 19 ·6920 Wellin, Belgium
BE 0842.494.785
Watch Print / PDF
Age14 yrs

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of CLOSSON is 0.9% (low). The 2023 annual accounts show equity of €1.60M and a net result of €-145k. Equity is growing by ~13.8% per year across the filed fiscal years. Its solvency ranks better than 95% of 526 sector peers (fiscal year 2023). The company has been active since 2012 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 6 annual accounts.

Trust signals

3 signals
Established
Founded in 2012, 14 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).

Administrative Flags

0 events
No administrative flags

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.9% Low
0%0,5%1,5%4%10%≥25%
Annual accounts: weaker financial profile +Higher-failure-rate sector +Long track record

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€-145k-89.3%
Working capital€877k-8.0%

Annual accounts & ratios

Source: NBB · 2023
Annual accounts filed on 26-11-2024 with the NBB · fiscal year 2023 · volledig
€-250k€0€250k€500k€750kOperating result 2019: €50k€50kNet result 2019: €394k€394kOperating result 2020: €51k€51kNet result 2020: €463k€463kOperating result 2021: €62k€62kNet result 2021: €803k€803kOperating result 2022: €-91k€-91kNet result 2022: €-76k€-76kOperating result 2023: €-154k€-154kNet result 2023: €-145k€-145k20192020202120222023
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing Equity: growth of ~13.8%/year over 6 fiscal years, indicative, assuming unchanged policy.
€500k€1.00M€1.50M€2.00M€2.50M2024: €1.88M (€1.75M - €2.01M)2025: €2.14M (€1.93M - €2.35M)2026: €2.44M (€2.14M - €2.73M)2018: €891k2019: €955k2020: €1.02M2021: €1.82M2022: €1.75M2023: €1.60M201820192020202120222023202420252026
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2023 · NACE 46, Wholesale trade · compared within the same schema type (full schema)
Metric This company Sector median Position in the sector
Solvency 89.7% 30.2%
better than 95% of 526 sector peers
Net result €-145k €46k
better than 13% of 525 sector peers
Equity €1.60M €485k
better than 65% of 526 sector peers
Gross operating margin €-149k €109k
better than 5% of 323 sector peers
Total assets €1.79M €1.71M
better than 51% of 526 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
EBITDA
€-150k
-69.7% far below sector median
Net profit
€-145k
-89.3% far below sector median
Cash flow
€-141k
-89.2% far below sector median
Total assets
€1.79M
-4.3% far above sector median
Equity
€1.60M
-8.3% far above sector median
Working capital
€877k
-8.0% far above sector median
Income taxes
€443
-20.8% -67% vs sector
Debt
€184k
+54.9% +44% vs sector
Debt ≤ 1y
€158k
+40.0% +23% vs sector
Debt > 1y
€24k
-87.1% -94% vs sector
Current ratio
6.55
-30.6% +215% vs sector
Quick ratio
6.55
-30.6% +245% vs sector
Solvency
89.7%
-4.2% +82% vs sector
Debt / equity
0.12
+68.8% -89% vs sector
ROE
-9.0%
-106.4% +60% vs sector
ROA
-8.1%
-97.7% -2% vs sector
Interest coverage
-117.17
-1270.2% far below sector median
Figures by fiscal year
Fiscal year2023
Revenue-
EBITDA€-150k
Net profit€-145k
Cash flow€-141k
Staff costs-
Income taxes€443
Dividends-
Total assets€1.79M
Equity€1.60M
Debt€184k
of which ≤ 1y€158k
of which > 1y€24k
Working capital€877k
Employees (FTE)-
Ratios (computed)
2023
Current ratio6.55
Quick ratio6.55
Working capital ratio49.1%
Solvency89.7%
Debt / equity0.12
Long-term debt ratio0.02
Interest coverage-117.17
Gross margin-
Net margin-
ROA-8.1%
ROE-9.0%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2023
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2023
Balance sheet, Assets
TOTAL ASSETS 20/58€1.79M
Fixed assets 21/28€752k
Tangible fixed assets 22/27€88k
Financial fixed assets 28€664k
Current assets 29/58€1.03M
Amounts receivable within one year 40/41€963k
Cash & bank 54/58€27k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€1.79M
Equity 10/15€1.60M
Contributions / capital 10/11€500k
Reserves 13€50k
Accumulated profits (losses) 14€1.05M
Amounts payable 17/49€184k
Amounts payable after one year 17€24k
Amounts payable within one year 42/48€158k
Trade debts payable within one year 44€124k
Income statement
Gross operating margin 9900€-149k
Operating result 9901€-154k
Financial income 75€11k
Financial charges 65€1k
Result before taxes 9903€-144k
Income taxes 67/77€443
Net result for the period 9904€-145k
Result to be appropriated 9905€-145k
You're seeing the latest fiscal year only. Unlock 4 prior years (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2023 · computed
52 / 100 Fair
050100

Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.

See plans →
Computed by Checked from NBB filings and Belgian State Gazette signals. Indicative, not credit advice.

Structure & network

Locations & real estate

Establishment units

1 location
SPRL CLOSSON
Rue Houchettes 19, 6920 WellinGroothandel in farmaceutische en medische artikelen
since 20122.205.556.997
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area4,954 m²
Buildings1
Building footprint174 m²
Volume (LiDAR)1,559 m³
Tallest building10.4 m · ±3 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
84075B1190/00D000 Wallonia 4,954 m² 1 · 174 m² 10.4 m · 3 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Analysis

Snowflake analysis

financial profile on 5 axes
Health52Profitability0Solvency100Growth52Stability100
61 / 100

Strong profile, led by solvency.

Health 52
Profitability 0
Solvency 100
Growth 52
Stability 100

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
AI-generated from Checked data; indicative, not legal or investment advice.

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Same sector, ranked by comparable size

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Groothandel in farmaceutische producten46460Groothandel in farmaceutische en medische artikelen46460
Primary activity highlighted.
Names & trade names
Legal nameFR CLOSSON
Registered office
Rue Houchettes 19 bus 1
6920 Wellin, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.